Announce Date | 05/02/2024 |
EPS Normalized Actual | $0.11 (Beat by $0.03) |
EPS GAAP Actual | $0.11 (Beat by $0.03) |
Revenue Actual | $0.282407B |
Revenue Surprise | Beat by $282.407M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $0.20973 |
EPS GAAP Estimate | $0.20973 |
Revenue Estimate | $0.238337212B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.41 | 19.26 | 2.24755 | 2.54431 | 2 |
Dec 2027 | 2.13 | 21.79 | 1.98643 | 2.2487 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.39 | 0.39 | 0.282407B | 100% | 282.41M |
FQ4 2021 (Oct 2021) | 0.45 | 0.45 | 0.284848B | 21.5% | 284.85M |
FQ2 2021 (Apr 2021) | 0.4 | 0.4 | 0.239027B | 29.26% | 239.03M |
FQ4 2020 (Dec 2020) | 0.401114 | 0.401114 | 0.223615B | 24.08% | 223.62M |
FQ3 2020 (Sep 2020) | 0.5 | 0.5 | 0.251073B | 26.98% | 251.07M |
FQ2 2020 (Jun 2020) | -0.00662863 | -0.00662863 | 0.169097B | -17.71% | 169.1M |
FQ1 2020 (Mar 2020) | 0.12 | 0.12 | 0.167235B | 100% | 167.24M |
FQ4 2019 (Dec 2019) | 0.47 | 0.47 | 0.169769B | 100% | 169.77M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
0.20973
Consensus Revenue Estimates
0.238337212B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.32617 | -- | 0.30377 | 0.34881 | 7 |
FQ3 2025 (Jul 2025) | 0.28747 | -- | 0.26773 | 0.30742 | 8 |
FQ2 2025 (Jun 2025) | 0.30708 | -- | 0.28357 | 0.33019 | 6 |
FQ1 2025 (Mar 2025) | 0.14263 | -- | 0.13171 | 0.15337 | 4 |
FQ4 2024 (Oct 2024) | 1.54141 | -- | 1.28975 | 2.10764 | 1 |
FQ3 2024 (Jul 2024) | 1.34259 | -- | 1.12339 | 1.83579 | 3 |
FQ2 2024 (Jun 2024) | 0.20973 | -- | 0.17478 | 0.25634 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.27B | -- | 0.26B | 0.29B | 6 |
FQ3 2025 (Jul 2025) | 0.27B | -- | 0.26B | 0.28B | 7 |
FQ2 2025 (Jun 2025) | 0.27B | -- | 0.26B | 0.29B | 3 |
FQ1 2025 (Mar 2025) | 0.23B | -- | 0.22B | 0.24B | 5 |
FQ4 2024 (Oct 2024) | 0.39B | -- | 0.38B | 0.41B | 2 |
FQ3 2024 (Jul 2024) | 0.35B | -- | 0.33B | 0.36B | 2 |
FQ2 2024 (Jun 2024) | 0.24B | -- | 0.22B | 0.26B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.39 | 0.39 | 100% | |
FQ4 2021 (Oct 2021) | 0.45 | 0.45 | 100% | |
FQ2 2021 (Apr 2021) | 0.4 | 0.4 | 100% | |
FQ4 2020 (Dec 2020) | 0.401114 | 0.401114 | 100% | |
FQ3 2020 (Sep 2020) | 0.5 | 0.5 | 100% | |
FQ2 2020 (Jun 2020) | -0.00662863 | -0.00662863 | 100% | |
FQ1 2020 (Mar 2020) | 0.12 | 0.12 | 100% | |
FQ4 2019 (Dec 2019) | 0.47 | 0.47 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.28B | $282.41M | 100% |
FQ4 2021 (Oct 2021) | $0B | $0.28B | $284.85M | 100% |
FQ2 2021 (Apr 2021) | $0B | $0.24B | $239.03M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.22B | $223.62M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.25B | $251.07M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.17B | $169.1M | 100% |
FQ1 2020 (Mar 2020) | $0B | $0.17B | $167.24M | 100% |
FQ4 2019 (Dec 2019) | $0B | $0.17B | $169.77M | 100% |